Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Crispr Therapeutics AG

Crispr Therapeutics AG

CRSP · NASDAQ
CRSP · NASDAQ
51.98
USD-0.95-1.80%

Latest News

    Seeking Alpha

    Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

      Seeking Alpha

      Cathie Wood's weekly recap: ramps up bets on JOBY, CRSP, pares ILMN, VCYT

        @cryptomocho
        cryptomocho

        added only bio stunks to my porfolio and tesla $NTLA $BEAM $CRSP $EDIT $VERV $DNA $ADAP and my bigest one $intx https://t.co/jy9Q2ROAnB

          Seeking Alpha

          ERYP, CRSP, ICVX and AMZN among after-hours movers

            Seeking Alpha

            PUBM, WB, GBS and CRSP among after-hours movers

              @DanZanger
              DanZanger

              $CRSP - Super gains for this speculative name https://t.co/ac1PFpAF1c

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              51.49USD
              52.77USD

              52 Week Range

              44.12USD
              78.48USD

              Market Cap

              5BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              CH0334081137

              CUSIP

              H17182108

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -0.21

              Book Value

              18.07

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -4.71

              Wall Street Target Price

              87.56

              EPS Estimate Current Year

              -4.45

              EPS Estimate Next Year

              -3.50

              EPS Estimate Current Quarter

              -1.1837

              EPS Estimate Next Quarter

              -1.1752

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              13,392,000

              Gross Profit TTM

              -461,800,992

              EBITDA

              -513,174,016

              Profit Margin

              0.00%

              Return On Assets TTM

              -14.20%

              Return On Equity TTM

              -26.10%

              Revenue Per Share TTM

              0.141

              Qtly Revenue Growth YOY

              1041.40%

              Diluted Eps TTM

              -4.71

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              23

              Price Sales TTM

              373.4277

              Price Book MRQ

              2.8633

              Enterprise Value Revenue

              310

              Enterprise Value EBITDA

              14

              Peers analysis

              • CSL Ltd
                CSLLYCSL Ltd

                30.72

                2.71%
              • UCB SA ADR
                UCBJYUCB SA ADR

                121.42

                1.73%
              • argenx SE
                ARGNFargenx SE

                1010.26

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                122.01

                -3.30%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                776.99

                -2.14%
              • Moderna Inc
                MRNAModerna Inc

                143.85

                -2.00%
              • UCB SA
                UCBJFUCB SA

                242.25

                -1.58%
              • argenx NV ADR
                ARGXargenx NV ADR

                976.00

                -1.37%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                514.63

                -0.96%
              • Revolution Medicines Inc
                RVMDRevolution Medicines Inc

                204.50

                -0.21%

              Curated watchlists where CRSP is featured.

              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Crispr Therapeutics AG stock price today?

              What is Crispr Therapeutics AG stock ticker?

              Is CRSP stock price going up?

              What is the analyst recommendation for CRSP?

              What is CRSP market cap?

              Does CRSP release financial reports?

              When is CRSP next earnings date?

              What were CRSP Earnings for the last quarter?

              What was CRSP Revenue for the last quarter?

              What was CRSP Net Income for the last quarter?

              Does CRSP pay dividends?

              How many employees does CRSP have?

              What is CRSP EBITDA?

              How to buy CRSP stocks?

              Should I invest in CRSP stock?

              What are you waiting for?Get started today
              ©
               2026 
              All rights reserved

              Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.

              Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.

              Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.